Piperazine, 1-(6-fluoro-1-naphthalenyl)-3-methyl-, (3R)-(439082-36-7)
- Name: Piperazine, 1-(6-fluoro-1-naphthalenyl)-3-methyl-, (3R)-
- Synonyms:
- Molecular Formula:C15H17FN2
- Molecular Weight:244.312
- CAS Registry Number:439082-36-7
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 439077-72-2/Benzenesulfonamide, 4-methyl-N-[2-methylene-1-(4-methylphenyl)-3-oxobutyl]-
- 439077-73-3/Benzenesulfonamide, N-[1-(4-methoxyphenyl)-2-methylene-3-oxobutyl]-4-methyl-
- 439077-74-4/Benzenesulfonamide, N-[1-(4-chlorophenyl)-2-methylene-3-oxobutyl]-4-methyl-
- 439077-75-5/Benzenesulfonamide, N-[1-(4-bromophenyl)-2-methylene-3-oxobutyl]-4-methyl-
- 439077-76-6/Benzenesulfonamide, N-[1-(2,3-dichlorophenyl)-2-methylene-3-oxobutyl]-4-methyl-
- 439077-77-7/Benzenesulfonamide, 4-methyl-N-[2-methylene-1-(4-nitrophenyl)-3-oxobutyl]-
- 439077-78-8/Benzenesulfonamide, N-[1-(3-fluorophenyl)-2-methylene-3-oxobutyl]-4-methyl-
- 439081-07-9/Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-5-methyl-2'-O-[2-[(trifluoroacet yl)amino]ethyl]-
- 439081-08-0/Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-5-methyl-2'-O-[2-[(trifluoroacet yl)amino]ethyl]-, 3'-(hydrogen butanedioate)
- 439081-10-4/2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-(cyclopentyloxy)-6-quinazolinyl]- 4-(dimethylamino)-
- 439081-12-6/2-Butenamide, N-[7-(cyclopropylmethoxy)-4-[[(1R)-1-phenylethyl]amino]-6-quinazolinyl]- 4-[ethyl(2-methoxyethyl)amino]-
- 439081-13-7/2-Butenamide, N-[7-(cyclopropylmethoxy)-4-[[(1R)-1-phenylethyl]amino]-6-quinazolinyl]- 4-[(2-methoxyethyl)methylamino]-
- 439081-14-8/2-Butenamide, N-[7-(cyclopropylmethoxy)-4-[[(1R)-1-phenylethyl]amino]-6-quinazolinyl]- 4-[methyl(tetrahydro-2H-pyran-4-yl)amino]-
- 439081-17-1/R-Afatinib
- 439081-25-1/2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[(tetrahydro-2-furanyl)methoxy]- 6-quinazolinyl]-4-(4-morpholinyl)-
- 439081-26-2/2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-(cyclopentyloxy)-6-quinazolinyl]- 4-[(2-methoxyethyl)methylamino]-
- 439081-30-8/2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-(cyclopentyloxy)-6-quinazolinyl]- 4-(cyclopropylmethylamino)-
- 439081-39-7/2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(2R)-tetrahydro-2-furanyl]meth oxy]-6-quinazolinyl]-4-(dimethylamino)-
- 439081-40-0/2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(2S)-tetrahydro-2-furanyl]meth oxy]-6-quinazolinyl]-4-(dimethylamino)-
- 439082-36-7/Piperazine, 1-(6-fluoro-1-naphthalenyl)-3-methyl-, (3R)-
- 439083-19-9/Benzo[b]thiophene, 6-bromo-4-chloro-
- 439083-90-6/BAY 60-7550
- 439084-54-5/1-Undecanethiol, 11-[2-(2-aminoethoxy)ethoxy]-
- 439084-62-5/Spiro[dithiirane-3,2'-[2H]indene], 1',3'-dihydro-1',1',3',3'-tetramethyl-, 1-oxide
- 439085-04-8/Piperidine, 3-ethyl-2-phenyl-, (2R,3R)-
- 439087-27-1/Glycine, (2R)-N-[[[3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5- phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- 439087-34-0/b-Alanine, (2R)-N-[[[3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5- phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- 439087-37-3/Hexanoic acid, 6-[[(2R)-[[[[3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido- 5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]amino]phenylacetyl]amino]-
- 439087-60-2/L-Serine, (2R)-N-[[[3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5- phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- 439088-00-3/Ethanesulfonic acid, 2-[[(2R)-[[[[3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido- 5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]amino]phenylacetyl]amino]-